Few studies have characterized the effect of anti migraine medications on children. Since most young children cannot accurately describe their symptoms, finding biomarkers that can guide the choice of migraine treatment is crucial.
In this study, the scientists explore whether CGRP could be a biomarker helping stratification of migrainous children, by studying the relation between plasma CGRP levels and the responses to anti migraine therapies.